Live Chat

AbbVie實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期  關閉 更改 更改(%): 開倉

最新新聞

Christine Voong 2024 Dec 20, 07:35

比特幣價格走勢:連跌三日,受聯準會鷹派立場與獲利了結影響,加密貨幣市場承壓

Christine Voong 2024 Dec 20, 02:53

美國商務部要求英偉達公司調查晶片流入中國途徑,分銷商合規性受關注

Christine Voong 2024 Dec 19, 08:40

黃金價格走勢:黃金價格從一個月低點反彈,聯準會鷹派立場壓抑市場樂觀情緒

Christine Voong 2024 Dec 19, 05:33

蘋果公司反擊Meta公司互操作請求,隱私與安全成爭議焦點,歐盟加強監管要求開放互操作

Christine Voong 2024 Dec 19, 03:42

聯準會降息後美股指數期貨企穩,科技股重挫引發華爾街震盪,市場聚焦2025年降息步伐

Christine Voong 2024 Dec 18, 04:56

亞洲股市普遍上漲,中國財政支出刺激市場走強,市場對聯準會利率決議保持觀望態度

Christine Voong 2024 Dec 18, 03:33

聯準會利率決議在即,美股指數期貨小幅下跌,道瓊斯工業指數創近半世紀最長連跌紀錄

So Ze Dong 2024 Dec 18, 01:00

美股道瓊工業指數創下最長九連跌記錄,專家預測聯準會在利率決策上可能是放更加鷹派訊號

聯絡方式

點差

1.16

點差(%)

0.6625 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期一

14:31 - 20:59

星期二

14:31-17:59

星期四

14:31-20:59

星期五

14:31-20:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

310274424832

流通股份

1767139968

收益日期(下一個)

0000-00-00

現金殖利率 

2025-02-14

除息日

2025-01-15

遠期年股息率

6.56

遠期年現金殖利率

0.0374

每股盈餘

2.86

了解有關此金融工具的詳細資訊

AbbVie AbbVie Inc
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; Evolveimmune Therapeutics, Inc.; Genentech, Inc.; and Tentarix Biotherapeutics, LP. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具
Trustpilot
Live Chat